257 related articles for article (PubMed ID: 24631448)
21. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
22. Unconventional approaches to the prevention of cancer associated thrombosis.
Zwicker JI
Thromb Res; 2014 May; 133 Suppl 2():S44-8. PubMed ID: 24862145
[TBL] [Abstract][Full Text] [Related]
23. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
[TBL] [Abstract][Full Text] [Related]
24. Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?
Bozic KJ; Vail TP; Pekow PS; Maselli JH; Lindenauer PK; Auerbach AD
J Arthroplasty; 2010 Oct; 25(7):1053-60. PubMed ID: 19679434
[TBL] [Abstract][Full Text] [Related]
25. Association of statins, aspirin, and venous thromboembolism in women with endometrial cancer.
Matsuo K; Hom MS; Yabuno A; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
Gynecol Oncol; 2019 Mar; 152(3):605-611. PubMed ID: 30616901
[TBL] [Abstract][Full Text] [Related]
26. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
[TBL] [Abstract][Full Text] [Related]
27. Antiplatelet therapy use and the risk of venous thromboembolic events in the Raloxifene Use for the Heart (RUTH) trial.
Duvernoy CS; Yeo AA; Wong M; Cox DA; Kim HM
J Womens Health (Larchmt); 2010 Aug; 19(8):1459-65. PubMed ID: 20626269
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism in burn patients is not prevented by chemoprophylaxis.
Sikora S; Papp A
Burns; 2017 Sep; 43(6):1330-1334. PubMed ID: 28736179
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
30. The Role of Aspirin and Unfractionated Heparin Combination Therapy Immediately After Total Hip and Knee Arthroplasty.
Sobh AH; Koueiter DM; Mells A; Siljander MP; Karadsheh MS
Orthopedics; 2018 May; 41(3):171-176. PubMed ID: 29570760
[TBL] [Abstract][Full Text] [Related]
31. The timing of venous thromboembolism in ovarian cancer patients: A nationwide Danish cohort study.
Strøm Kahr H; Christiansen OB; Juul Riddersholm S; Gade IL; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
J Thromb Haemost; 2021 Apr; 19(4):992-1000. PubMed ID: 33420762
[TBL] [Abstract][Full Text] [Related]
32. Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study.
Schmidt M; Cannegieter SC; Johannesdottir SA; Dekkers OM; Horváth-Puhó E; Sørensen HT
J Thromb Haemost; 2014 Aug; 12(8):1207-15. PubMed ID: 24818818
[TBL] [Abstract][Full Text] [Related]
33. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
[TBL] [Abstract][Full Text] [Related]
34. The use of antithrombotic drugs in older people.
Tufano A; Cerbone AM; Di Minno G
Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
[TBL] [Abstract][Full Text] [Related]
35. A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy.
Zou PM; Li H; Cai JF; Chen ZJ; Li C; Xu P; Li MX; Chen LM; Li XM; Li XW
Chin Med Sci J; 2018 Jun; 33(2):91-99. PubMed ID: 29976278
[TBL] [Abstract][Full Text] [Related]
36. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
37. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data.
Jameson SS; Baker PN; Charman SC; Deehan DJ; Reed MR; Gregg PJ; Van der Meulen JH
J Bone Joint Surg Br; 2012 Jul; 94(7):914-8. PubMed ID: 22733945
[TBL] [Abstract][Full Text] [Related]
38. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism after severe trauma: incidence, risk factors and outcome.
Paffrath T; Wafaisade A; Lefering R; Simanski C; Bouillon B; Spanholtz T; Wutzler S; Maegele M;
Injury; 2010 Jan; 41(1):97-101. PubMed ID: 19608183
[TBL] [Abstract][Full Text] [Related]
40. ASH evidence-based guidelines: statins in the prevention of venous thromboembolism.
Evans NS; Green D
Hematology Am Soc Hematol Educ Program; 2009; ():273-4. PubMed ID: 20008210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
